NASDAQ · Healthcare · Biotechnology
Alamar Biosciences, Inc.
ALMR
Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. CEO Justin J. McAnear · Market cap $250.0M.
$26.67
-0.20 · -0.74%
52w hi $28.2352w lo $18.85
Off 52w high 0.8%
69
NOTABLE
Current InsiderScore
Corp · 90d
2
2 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
2
0 strong · 2 notable
Analyst consensus
—
—
Section 01
Recent Form 4 filings
2 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Apr 20 | Illumina Innovation Fund II GP, L.L.C. | Buy | 235,294 | $17.00 | +$4.00M | 69 | |
| Apr 20 | Nicholas Naclerio | Buy | 235,294 | $17.00 | +$4.00M | 65 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JulAugSepOctNovDecJanFebMarAprMayJun